Cargando…
P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428354/ http://dx.doi.org/10.1097/01.HS9.0000968228.81299.a0 |
| _version_ | 1785090448636772352 |
|---|---|
| author | Roeten, Margot van Dijk, Suzanne van Meerloo, Johan Kwidama, Zinia Jenkins, Gaya Teachey, David Devidas, Meenakshi Loh, Mignon Kaspers, Gertjan Zweegman, Sonja Jansen, Gerrit Horton, Terzah Cloos, Jacqueline |
| author_facet | Roeten, Margot van Dijk, Suzanne van Meerloo, Johan Kwidama, Zinia Jenkins, Gaya Teachey, David Devidas, Meenakshi Loh, Mignon Kaspers, Gertjan Zweegman, Sonja Jansen, Gerrit Horton, Terzah Cloos, Jacqueline |
| author_sort | Roeten, Margot |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428354 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283542023-08-17 P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231 Roeten, Margot van Dijk, Suzanne van Meerloo, Johan Kwidama, Zinia Jenkins, Gaya Teachey, David Devidas, Meenakshi Loh, Mignon Kaspers, Gertjan Zweegman, Sonja Jansen, Gerrit Horton, Terzah Cloos, Jacqueline Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428354/ http://dx.doi.org/10.1097/01.HS9.0000968228.81299.a0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Roeten, Margot van Dijk, Suzanne van Meerloo, Johan Kwidama, Zinia Jenkins, Gaya Teachey, David Devidas, Meenakshi Loh, Mignon Kaspers, Gertjan Zweegman, Sonja Jansen, Gerrit Horton, Terzah Cloos, Jacqueline P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231 |
| title | P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231 |
| title_full | P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231 |
| title_fullStr | P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231 |
| title_full_unstemmed | P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231 |
| title_short | P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231 |
| title_sort | p329: high immunoproteasome activity as novel indicator for sensitivity to bortezomib-containing chemotherapy in acute lymphoblastic leukemia patients from children’s oncology group trial aall1231 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428354/ http://dx.doi.org/10.1097/01.HS9.0000968228.81299.a0 |
| work_keys_str_mv | AT roetenmargot p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT vandijksuzanne p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT vanmeerloojohan p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT kwidamazinia p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT jenkinsgaya p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT teacheydavid p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT devidasmeenakshi p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT lohmignon p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT kaspersgertjan p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT zweegmansonja p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT jansengerrit p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT hortonterzah p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 AT cloosjacqueline p329highimmunoproteasomeactivityasnovelindicatorforsensitivitytobortezomibcontainingchemotherapyinacutelymphoblasticleukemiapatientsfromchildrensoncologygrouptrialaall1231 |